Information for Shareholders and Investors

Last news and press notes.

  • 26 jan, 2016

    Grifols invests in the project led by AlbaJuna Therapeutics, a spin-off from IrsiCaixa, to fund the development of therapeutic antibodies against HIV Download (249.7 Kb)

  • 14 dec, 2015

    Grifols makes public its succession plan: the envisaged generational handover reiterates the commitment of the founding family to the company Download (22.3 Kb)

  • 06 nov, 2015

    The intermediate results from the Grifols AMBAR study support its continuation Download (31.1 Kb)